Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Therapies
100,0
%
| 13 | 100,0 % | 16 | 100,0 % | +16,98% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States, Ireland and United Kingdom
100,0
%
| 13 | 100,0 % | 16 | 100,0 % | +16,98% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
David Apelian
CEO | Chief Executive Officer | 59 | 14/06/17 |
James Vollins
CMP | Compliance Officer | 55 | 13/04/23 |
Colin Hislop
CTO | Chief Tech/Sci/R&D Officer | 66 | - |
Chief Tech/Sci/R&D Officer | 57 | 18/04/22 | |
General Counsel | - | 01/04/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 57 | 18/07/22 | |
Thomas Dietz
CHM | Chairman | 60 | 22/03/16 |
David Apelian
CEO | Chief Executive Officer | 59 | 14/06/17 |
Amit Sachdev
BRD | Director/Board Member | 56 | 15/04/19 |
Evan Loh
BRD | Director/Board Member | 65 | 18/09/17 |
Kim Sablich
BRD | Director/Board Member | 55 | 23/04/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 480 797 | 1 262 028 ( 85,23 %) | 0 | 85,23 % |
Coordinate società
Eiger BioPharmaceuticals, Inc.
2155 Park Boulevard
94306-1543, Palo Alto
+650 272 6138
http://www.eigerbio.com![Indirizzo Celladon Corp](https://cdn.zonebourse.com/static/address/14904440.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+17,20% | 44,44 Mrd | |
-10,10% | 37,99 Mrd | |
+37,55% | 37,75 Mrd | |
+29,37% | 30,78 Mrd | |
-8,44% | 27,38 Mrd | |
+12,25% | 26,17 Mrd | |
+45,28% | 14,15 Mrd | |
+31,66% | 12,59 Mrd | |
-7,37% | 11,28 Mrd |